Blumenschein, George <br/><br/>
Sorafenib in lung cancer: clinical developments and future directions.  [electronic resource] 

 -  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer  Jun 2008 
 - S124-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1556-1380 
<br/><br/><label>Standard No.: </label>10.1097/JTO.0b013e318174e085  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Benzenesulfonates--administration & dosage<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Female<br/>Follow-Up Studies<br/>Forecasting<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Neoplasm Staging<br/>Neovascularization, Pathologic--prevention & control<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds<br/>Pyridines--administration & dosage<br/>Randomized Controlled Trials as Topic<br/>Receptors, Vascular Endothelial Growth Factor--antagonists & inhibitors<br/>Risk Assessment<br/>Sorafenib<br/>Survival Analysis<br/>Treatment Outcome<br/>Vascular Endothelial Growth Factors--antagonists & inhibitors